S-Dihydrodaidzein and 3-(1,3-benzoxazol-2-yl)-benzamide, Two New Potential β-estrogen Receptor Ligands with Anti-adipogenic Activity.

María F Torres-Rojas Gilberto Mandujano-Lazaro Cesar López-Camarillo Esther Ramírez-Moreno Domingo Mendez-Alvarez Gildardo Rivera Laurence A Marchat

Published in: Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)

Altogether, these results show the two new potential β-estrogen receptor ligands, C1 and C2, to exhibit anti-adipogenic activity. They could further be used as lead structures for the development of more efficient drugs for obesity control.

Keyphrases

estrogen receptor
metabolic syndrome
type diabetes
insulin resistance
weight loss
human health
high resolution
mass spectrometry
climate change